Targeted cancer therapies have transformed the treatment of certain blood and solid cancers. Unnati Pharmax, a trusted pharmaceutical exporter from India, supplies Veenat 400 mg Tablets, containing Imatinib Mesylate 400 mg, a widely used targeted anticancer medicine.
Veenat 400 is globally prescribed for the treatment of chronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GIST), offering effective disease control with long-term use.
What is Veenat 400 mg Tablet?
Veenat 400 mg Tablet contains:
-
Imatinib Mesylate – 400 mg
Imatinib is a tyrosine kinase inhibitor (TKI) that targets specific cancer-causing proteins, making it a cornerstone therapy in precision oncology.
Uses of Veenat 400 mg Tablet
Veenat 400 mg is commonly prescribed for:
-
Chronic Myeloid Leukemia (CML)
-
Acute Lymphoblastic Leukemia (Ph+ ALL)
-
Gastrointestinal Stromal Tumors (GIST)
-
Myelodysplastic / Myeloproliferative diseases
-
Other rare cancers, as advised by an oncologist
How Does Imatinib Work?
Imatinib works by:
-
Blocking abnormal tyrosine kinase enzymes
-
Preventing cancer cell growth and division
-
Targeting cancer cells without harming most normal cells
-
Helping achieve long-term disease control
This targeted action improves survival and quality of life in many patients.
Dosage and Administration
-
Usually taken once daily, with food and water
-
Dosage depends on cancer type and patient response
-
Long-term, continuous treatment may be required
⚠️ Always take Veenat 400 mg exactly as prescribed by a healthcare professional.
Possible Side Effects
Some patients may experience:
-
Nausea or vomiting
-
Fluid retention or swelling
-
Muscle cramps
-
Fatigue
-
Mild skin rash
Side effects are usually manageable under medical supervision.
Why Choose Unnati Pharmax for Veenat 400 mg Tablet?
Unnati Pharmax is a reliable exporter of oncology and specialty medicines from India.
Our Key Advantages
-
WHO-GMP compliant manufacturing partners
-
Competitive export pricing
-
Complete regulatory & export documentation
-
Secure global logistics support
-
Bulk supply & long-term distribution options
We export Veenat 400 mg Tablets to Africa, Asia, Latin America, and other regulated and semi-regulated markets.
Product Details
-
Product Name: Veenat 400 mg Tablet
-
Active Ingredient: Imatinib Mesylate 400 mg
-
Dosage Form: Tablet
-
Therapeutic Category: Anticancer / Targeted Therapy
-
Packaging: Export-oriented packing available
FAQs – Veenat 400 mg Tablet
What is Veenat 400 mg used for?
It is mainly used to treat chronic myeloid leukemia (CML) and GIST tumors.
Is Veenat 400 a chemotherapy drug?
No. Veenat 400 is a targeted cancer therapy, not traditional chemotherapy.
Can Unnati Pharmax export Veenat 400 mg Tablets?
Yes. Unnati Pharmax exports Veenat 400 mg Tablets from India with full regulatory compliance.
Is a prescription required?
Yes. Veenat 400 mg is a prescription-only oncology medicine.
How long is Veenat 400 taken?
Treatment duration depends on the disease and patient response and is decided by the oncologist.
Conclusion
Veenat 400 mg Tablet (Imatinib Mesylate 400 mg) is a globally trusted targeted therapy for leukemia and other cancers. With a strong focus on quality, affordability, and reliable international supply, Unnati Pharmax ensures uninterrupted access to this life-saving oncology medicine worldwide.
📩 Contact Unnati Pharmax today for export inquiries, bulk orders, or oncology distribution partnerships. phone8669251513
